ARYZTA AG
ARYZTA AG (ARZTF) Financial Performance & Income Statement Overview
Explore the financials of ARYZTA AG (ARZTF), including yearly and quarterly data on income, cash flow, and balance sheets.
ARYZTA AG (ARZTF) Income Statement & Financial Overview
Analyze ARYZTA AG’s ARZTF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q4 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|
| Revenue | $1.06B | $1.09B | $1.04B | $920.80M |
| Cost of Revenue | $830.60M | $875.10M | $855.80M | $754.50M |
| Gross Profit | $224.60M | $211.00M | $181.30M | $166.30M |
| Gross Profit Ratio | $0.21 | $0.19 | $0.17 | $0.18 |
| R&D Expenses | $0.00 | $5.90M | $0.00 | $5.40M |
| SG&A Expenses | $139.00M | $132.90M | $115.70M | $114.70M |
| Operating Expenses | $139.00M | $132.80M | $115.70M | $117.10M |
| Total Costs & Expenses | $969.60M | $1.008B | $971.50M | $871.60M |
| Interest Income | $0.00 | $7.27M | $1.97M | $840628.00 |
| Interest Expense | $0.00 | $21.39M | $10.43M | $9.25M |
| Depreciation & Amortization | $41.20M | $39.80M | $41.80M | $18.80M |
| EBITDA | $126.80M | $117.90M | $107.40M | $70.40M |
| EBITDA Ratio | $0.12 | $0.11 | $0.10 | $0.08 |
| Operating Income | $85.60M | $78.20M | $65.60M | $51.60M |
| Operating Income Ratio | $0.08 | $0.07 | $0.06 | $0.06 |
| Other Income/Expenses (Net) | -$16.10M | -$13.80M | -$8.60M | -$8.60M |
| Income Before Tax | $69.50M | $64.40M | $57.00M | $41.20M |
| Income Before Tax Ratio | $0.07 | $0.06 | $0.05 | $0.04 |
| Income Tax Expense | $11.40M | $4.10M | $5.30M | $1.40M |
| Net Income | $58.10M | $60.30M | $27.20M | $20.10M |
| Net Income Ratio | $0.06 | $0.06 | $0.03 | $0.02 |
| EPS | $0.03 | $0.04 | $0.03 | $0.02 |
| Diluted EPS | $0.04 | $0.06 | $0.03 | $0.02 |
| Weighted Avg Shares Outstanding | $1.42B | $1.60B | $1.007B | $1.006B |
| Weighted Avg Shares Outstanding (Diluted) | $996.60M | $995.90M | $993.70M | $992.40M |
Financial performance has remained strong, with revenue growing from $920.80M in Q4 2022 to $1.06B in Q4 2024. Gross profit continued to perform well, with margins at 21% in the latest quarter. Operating income reached $85.60M in Q4 2024, holding a steady 8% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $126.80M. Net income dropped to $58.10M, keeping EPS at $0.03. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan